A systematic review, meta-analysis, and meta-regression evaluating the efficacy and mechanisms of action of probiotics and synbiotics in the prevention of surgical site infections and surgery-related complications

Journal of Clinical Medicine

Volumn 7, Issue 12, 2018, Pages

  Skonieczna żydecka, Karolina ^a   Kaczmarczyk, Mariusz ^a   Łoniewski, Igor ^a   Lara, Luis F ^b   Koulaouzidis, Anastasios ^c   Misera, Agata ^d   Maciejewska, Dominika ^a   Marlicz, Wojciech ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adverse events; Meta analysis; Microbiota; Prebiotics; Probiotics; Surgery; Surgical site infections (SSIs); Synbiotics; Systematic review

Indexed keywords

ACETIC ACID; AMINE OXIDASE (COPPER CONTAINING); BUTYRIC ACID; C REACTIVE PROTEIN; CALGRANULIN; INTERLEUKIN 6; PEPTIDES AND PROTEINS; PROBIOTIC AGENT; PROPIONIC ACID; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; ZONULIN;

ADULT; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; FEVER; HUMAN; IMMUNE RESPONSE; INCIDENCE; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; META ANALYSIS; MORTALITY; RISK FACTOR; SURGICAL INFECTION; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

EID: 85068796332     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm7120556     Document Type: Article

References (112)

1. GlobalSurg Collaborative. Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: A prospective, international, multicentre cohort study. Lancet Infect. Dis. 2018, 18, 516–525. [CrossRef]
2. Guyton, K.; Alverdy, J.C. The gut microbiota and gastrointestinal surgery. Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 43–54. [CrossRef] [PubMed]
3. WHO. Global Guidelines on the Prevention of Surgical Site Infection. Available online: http://www.who.in t/gpsc/ssi-guidelines/en/(accessed on 7 September 2018).
4. Berríos-Torres, S.I.; Umscheid, C.A.; Bratzler, D.W.; Leas, B.; Stone, E.C.; Kelz, R.R.; Reinke, C.E.; Morgan, S.; Solomkin, J.S.; Mazuski, J.E.; et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017, 152, 784–791. [CrossRef]
5. Ban, K.A.; Minei, J.P.; Laronga, C.; Harbrecht, B.G.; Jensen, E.H.; Fry, D.E.; Itani, K.M.F.; Dellinger, E.P.; Ko, C.Y.; Duane, T.M. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J. Am. Coll. Surg. 2017, 224, 59–74. [CrossRef] [PubMed]
6. Stone, P.W.; Braccia, D.; Larson, E. Systematic review of economic analyses of health care-associated infections. Am. J. Infect. Control 2005, 33, 501–509. [CrossRef] [PubMed]
7. WHO Guidelines for Safe Surgery 2009: Safe Surgery Saves Lives; WHO Guidelines Approved by the Guidelines Review Committee; World Health Organization: Geneva, Switzerland, 2009; ISBN 978-92-4-159855-2.
8. Nguyen, N.; Yegiyants, S.; Kaloostian, C.; Abbas, M.A.; Difronzo, L.A. The Surgical Care Improvement project (SCIP) initiative to reduce infection in elective colorectal surgery: Which performance measures affect outcome? Am. Surg. 2008, 74, 1012–1016.
9. Altemeier, W.A.; Culbertson, W.R.; Hummel, R.P. Surgical considerations of endogenous infections—Sources, types, and methods of control. Surg. Clin. N. Am. 1968, 48, 227–240. [CrossRef]
10. Brial, F.; Le Lay, A.; Dumas, M.-E.; Gauguier, D. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases. Cell. Mol. Life Sci. 2018, 75, 3977–3990. [CrossRef]
11. Marlicz, W.; Yung, D.E.; Skonieczna-Żydecka, K.; Loniewski, I.; van Hemert, S.; Loniewska, B.; Koulaouzidis, A. From clinical uncertainties to precision medicine: The emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 961–978. [CrossRef]
12. Clemente, J.C.; Manasson, J.; Scher, J.U. The role of the gut microbiome in systemic inflammatory disease. BMJ 2018, 360, j5145. [CrossRef]
13. Spadoni, I.; Zagato, E.; Bertocchi, A.; Paolinelli, R.; Hot, E.; Sabatino, A.D.; Caprioli, F.; Bottiglieri, L.; Oldani, A.; Viale, G.; et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science 2015, 350, 830–834. [CrossRef] [PubMed]
14. Foster, J.A.; Rinaman, L.; Cryan, J.F. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol. Stress 2017, 7, 124–136. [PubMed]
15. Sonnenburg, J.L.; Bäckhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016, 535, 56–64. [CrossRef] [PubMed]
16. David, L.A.; Materna, A.C.; Friedman, J.; Campos-Baptista, M.I.; Blackburn, M.C.; Perrotta, A.; Erdman, S.E.; Alm, E.J. Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2014, 15, R89. [CrossRef] [PubMed]
17. Scarborough, J.E.; Mantyh, C.R.; Sun, Z.; Migaly, J. Combined Mechanical and Oral Antibiotic Bowel Preparation Reduces Incisional Surgical Site Infection and Anastomotic Leak Rates after Elective Colorectal Resection: An Analysis of Colectomy-Targeted ACS NSQIP. Ann. Surg. 2015, 262, 331–337. [CrossRef] [PubMed]
18. Bretagnol, F.; Panis, Y.; Rullier, E.; Rouanet, P.; Berdah, S.; Dousset, B.; Portier, G.; Benoist, S.; Chipponi, J.; Vicaut, E.; et al. Rectal cancer surgery with or without bowel preparation: The French GRECCAR III multicenter single-blinded randomized trial. Ann. Surg. 2010, 252, 863–868. [CrossRef] [PubMed]
19. Bachmann, R.; Leonard, D.; Delzenne, N.; Kartheuser, A.; Cani, P.D. Novel insight into the role of microbiota in colorectal surgery. Gut 2017, 66, 738–749. [CrossRef]
20. Hartman, A.L.; Lough, D.M.; Barupal, D.K.; Fiehn, O.; Fishbein, T.; Zasloff, M.; Eisen, J.A. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc. Natl. Acad. Sci. USA 2009, 106, 17187–17192. [CrossRef]
21. Shimizu, K.; Ogura, H.; Asahara, T.; Nomoto, K.; Matsushima, A.; Hayakawa, K.; Ikegawa, H.; Tasaki, O.; Kuwagata, Y.; Shimazu, T. Gut microbiota and environment in patients with major burns—A preliminary report. Burns 2015, 41, e28–e33. [CrossRef]
22. Earley, Z.M.; Akhtar, S.; Green, S.J.; Naqib, A.; Khan, O.; Cannon, A.R.; Hammer, A.M.; Morris, N.L.; Li, X.; Eberhardt, J.M.; et al. Burn Injury Alters the Intestinal Microbiome and Increases Gut Permeability and Bacterial Translocation. PLoS ONE 2015, 10, e0129996. [CrossRef]
23. Wang, F.; Li, Q.; He, Q.; Geng, Y.; Tang, C.; Wang, C.; Li, J. Temporal variations of the ileal microbiota in intestinal ischemia and reperfusion. Shock 2013, 39, 96–103. [CrossRef] [PubMed]
24. Gralka, E.; Luchinat, C.; Tenori, L.; Ernst, B.; Thurnheer, M.; Schultes, B. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner. Am. J. Clin. Nutr. 2015, 102, 1313–1322. [CrossRef] [PubMed]
25. Fan, P.; Li, L.; Rezaei, A.; Eslamfam, S.; Che, D.; Ma, X. Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut. Curr. Protein Pept. Sci. 2015, 16, 646–654. [CrossRef] [PubMed]
26. Ojima, M.; Motooka, D.; Shimizu, K.; Gotoh, K.; Shintani, A.; Yoshiya, K.; Nakamura, S.; Ogura, H.; Iida, T.; Shimazu, T. Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit Patients. Dig. Dis. Sci. 2016, 61, 1628–1634. [CrossRef] [PubMed]
27. Zaborin, A.; Smith, D.; Garfield, K.; Quensen, J.; Shakhsheer, B.; Kade, M.; Tirrell, M.; Tiedje, J.; Gilbert, J.A.; Zaborina, O.; et al. Membership and Behavior of Ultra-Low-Diversity Pathogen Communities Present in the Gut of Humans during Prolonged Critical Illness. mBio 2014, 5, e01361-14. [CrossRef] [PubMed]
28. Kasatpibal, N.; Whitney, J.D.; Saokaew, S.; Kengkla, K.; Heitkemper, M.M.; Apisarnthanarak, A. Effectiveness of Probiotic, Prebiotic, and Synbiotic Therapies in Reducing Postoperative Complications: A Systematic Review and Network Meta-analysis. Clin. Infect. Dis. 2017, 64, S153–S160. [CrossRef] [PubMed]
29. Wu, X.-D.; Xu, W.; Liu, M.-M.; Hu, K.-J.; Sun, Y.-Y.; Yang, X.-F.; Zhu, G.-Q.; Wang, Z.-W.; Huang, W. Efficacy of prophylactic probiotics in combination with antibiotics versus antibiotics alone for colorectal surgery: A meta-analysis of randomized controlled trials. J. Surg. Oncol. 2018, 117, 1394–1404. [CrossRef]
30. Arumugam, S.; Lau, C.S.M.; Chamberlain, R.S. Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: A Meta-Analysis. J. Gastrointest. Surg. 2016, 20, 1123–1131. [CrossRef]
31. Yang, Z.; Wu, Q.; Liu, Y.; Fan, D. Effect of Perioperative Probiotics and Synbiotics on Postoperative Infections after Gastrointestinal Surgery: A Systematic Review with Meta-Analysis. JPEN J. Parenter. Enter. Nutr. 2017, 41, 1051–1062. [CrossRef]
32. Lytvyn, L.; Quach, K.; Banfield, L.; Johnston, B.C.; Mertz, D. Probiotics and synbiotics for the prevention of postoperative infections following abdominal surgery: A systematic review and meta-analysis of randomized controlled trials. J. Hosp. Infect. 2016, 92, 130–139. [CrossRef]
33. Sawas, T.; Al Halabi, S.; Hernaez, R.; Carey, W.D.; Cho, W.K. Patients Receiving Prebiotics and Probiotics Before Liver Transplantation Develop Fewer Infections Than Controls: A Systematic Review and Meta-Analysis. Clin. Gastroenterol. Hepatol. 2015, 13, 1567–1574. [CrossRef] [PubMed]
34. Wu, X.-D.; Liu, M.-M.; Liang, X.; Hu, N.; Huang, W. Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: A meta-analysis with trial sequential analysis of randomized controlled trials. Clin. Nutr. 2018, 37, 505–515. [CrossRef] [PubMed]
35. Suez, J.; Zmora, N.; Zilberman-Schapira, G.; Mor, U.; Dori-Bachash, M.; Bashiardes, S.; Zur, M.; Regev-Lehavi, D.; Ben-Zeev Brik, R.; Federici, S.; et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell 2018, 174, 1406–1423.e16. [CrossRef] [PubMed]
36. Shamseer, L.; Moher, D.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A.; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015, 350, g7647. [CrossRef] [PubMed]
37. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177–188. [CrossRef]
38. Higgins, J.P.T.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savović, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A.C. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011, 343, d5928. [CrossRef]
39. Yang, Y.; Xia, Y.; Chen, H.; Hong, L.; Feng, J.; Yang, J.; Yang, Z.; Shi, C.; Wu, W.; Gao, R.; et al. The effect of perioperative probiotics treatment for colorectal cancer: Short-term outcomes of a randomized controlled trial. Oncotarget 2016, 7, 8432–8440. [CrossRef]
40. Kanazawa, H.; Nagino, M.; Kamiya, S.; Komatsu, S.; Mayumi, T.; Takagi, K.; Asahara, T.; Nomoto, K.; Tanaka, R.; Nimura, Y. Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbeck’s Arch. Surg. 2005, 390, 104–113. [CrossRef]
41. Aisu, N.; Tanimura, S.; Yamashita, Y.; Yamashita, K.; Maki, K.; Yoshida, Y.; Sasaki, T.; Takeno, S.; Hoshino, S. Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer. Exp. Ther. Med. 2015, 10, 966–972. [CrossRef]
42. Liu, Z.; Qin, H.; Yang, Z.; Xia, Y.; Liu, W.; Yang, J.; Jiang, Y.; Zhang, H.; Yang, Z.; Wang, Y.; et al. Randomised clinical trial: The effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—A double-blind study: Randomised clinical trial: Perioperative probiotics on colon cancer. Aliment. Pharmacol. Ther. 2011, 33, 50–63.
43. Eguchi, S.; Takatsuki, M.; Hidaka, M.; Soyama, A.; Ichikawa, T.; Kanematsu, T. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: A prospective randomized study. Am. J. Surg. 2011, 201, 498–502. [CrossRef] [PubMed]
44. Komatsu, S.; Sakamoto, E.; Norimizu, S.; Shingu, Y.; Asahara, T.; Nomoto, K.; Nagino, M. Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: A randomized controlled trial. Surg. Today 2016, 46, 479–490. [CrossRef] [PubMed]
45. Anderson, A.D.G. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004, 53, 241–245. [CrossRef] [PubMed]
46. Diepenhorst, G.M.P.; van Ruler, O.; Besselink, M.G.H.; van Santvoort, H.C.; Wijnandts, P.R.; Renooij, W.; Gouma, D.J.; Gooszen, H.G.; Boermeester, M.A. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: A randomized controlled trial. Shock 2011, 35, 9–16. [CrossRef] [PubMed]
47. Flesch, A.T.; Tonial, S.T.; Contu, P.D.C.; Damin, D.C. Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: A randomized, double-blind clinical trial. Rev. Col. Bras. Cir. 2017, 44, 567–573. [CrossRef] [PubMed]
48. Horvat, M.; Krebs, B.; Potrč, S.; Ivanecz, A.; Kompan, L. Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien. Klin. Wochenschr. 2010, 122, 26–30. [CrossRef]
49. Kotzampassi, K.; Stavrou, G.; Damoraki, G.; Georgitsi, M.; Basdanis, G.; Tsaousi, G.; Giamarellos-Bourboulis, E.J. A Four-Probiotics Regimen Reduces Postoperative Complications after Colorectal Surgery: A Randomized, Double-Blind, Placebo-Controlled Study. World J. Surg. 2015, 39, 2776–2783. [CrossRef] [PubMed]
50. Liu, Z.-H.; Huang, M.-J.; Zhang, X.-W.; Wang, L.; Huang, N.-Q.; Peng, H.; Lan, P.; Peng, J.-S.; Yang, Z.; Xia, Y.; et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: A double-center and double-blind randomized clinical trial. Am. J. Clin. Nutr. 2013, 97, 117–126. [CrossRef]
51. Liu, Z.; Li, C.; Huang, M.; Tong, C.; Zhang, X.; Wang, L.; Peng, H.; Lan, P.; Zhang, P.; Huang, N.; et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: A double-center and double-blind randomized clinical trial. BMC Gastroenterol. 2015, 15, 34. [CrossRef]
52. Mangell, P.; Thorlacius, H.; Syk, I.; Ahrné, S.; Molin, G.; Olsson, C.; Jeppsson, B. Lactobacillus plantarum 299v Does Not Reduce Enteric Bacteria or Bacterial Translocation in Patients Undergoing Colon Resection. Dig. Dis. Sci. 2012, 57, 1915–1924. [CrossRef]
53. McNaught, C.E. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002, 51, 827–831. [CrossRef] [PubMed]
54. Nomura, T.; Tsuchiya, Y.; Nashimoto, A.; Yabusaki, H.; Takii, Y.; Nakagawa, S.; Sato, N.; Kanbayashi, C.; Tanaka, O. Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 2007, 54, 661–663. [PubMed]
55. Okazaki, M.; Matsukuma, S.; Suto, R.; Miyazaki, K.; Hidaka, M.; Matsuo, M.; Noshima, S.; Zempo, N.; Asahara, T.; Nomoto, K. Perioperative synbiotic therapy in elderly patients undergoing gastroenterological surgery: A prospective, randomized control trial. Nutrition 2013, 29, 1224–1230. [CrossRef] [PubMed]
56. Zhang, J.-W.; Du, P.; Yang, B.-R.; Gao, J.; Fang, W.-J.; Ying, C.-M. Preoperative Probiotics Decrease Postoperative Infectious Complications of Colorectal Cancer. Am. J. Med. Sci. 2012, 343, 199–205. [CrossRef] [PubMed]
57. Yokoyama, Y.; Nishigaki, E.; Abe, T.; Fukaya, M.; Asahara, T.; Nomoto, K.; Nagino, M. Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy: Synbiotic treatment for patients who undergo oesophagectomy. Br. J. Surg. 2014, 101, 189–199. [CrossRef] [PubMed]
58. Usami, M.; Miyoshi, M.; Kanbara, Y.; Aoyama, M.; Sakaki, H.; Shuno, K.; Hirata, K.; Takahashi, M.; Ueno, K.; Tabata, S.; et al. Effects of Perioperative Synbiotic Treatment on Infectious Complications, Intestinal Integrity, and Fecal Flora and Organic Acids in Hepatic Surgery with or without Cirrhosis. J. Parenter. Enter. Nutr. 2011, 35, 317–328. [CrossRef] [PubMed]
59. Tanaka, K.; Yano, M.; Motoori, M.; Kishi, K.; Miyashiro, I.; Ohue, M.; Ohigashi, H.; Asahara, T.; Nomoto, K.; Ishikawa, O. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trial. Surgery 2012, 152, 832–842. [CrossRef] [PubMed]
60. Sommacal, H.M.; Bersch, V.P.; Vitola, S.P.; Osvaldt, A.B. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: A randomized, double-blind clinical trial. Nutr. Cancer 2015, 67, 457–462. [CrossRef]
61. Sadahiro, S.; Suzuki, T.; Tanaka, A.; Okada, K.; Kamata, H.; Ozaki, T.; Koga, Y. Comparison between oral antibiotics and probiotics as bowel preparation for elective colon cancer surgery to prevent infection: Prospective randomized trial. Surgery 2014, 155, 493–503. [CrossRef]
62. Reddy, B.S.; MacFie, J.; Gatt, M.; Larsen, C.N.; Jensen, S.S.; Leser, T.D. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br. J. Surgery 2007, 94, 546–554. [CrossRef]
63. Rammohan, A.; Sathyanesan, J.; Rajendran, K.; Pitchaimuthu, A.; Perumal, S.K.; Balaraman, K.; Ramasamy, R.; Palaniappan, R.; Govindan, M. Synbiotics in Surgery for Chronic Pancreatitis: Are They Truly Effective? A Single-blind Prospective Randomized Control Trial. Ann. Surg. 2015, 262, 31–37. [CrossRef] [PubMed]
64. Grat, M.; Wronka, K.M.; Lewandowski, Z.; Grat, K.; Krasnodębski, M.; Stypułkowski, J.; Hołówko, W.; Masior, Ł.; Kosińska, I.; Wasilewicz, M.; et al. Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2017, 36, 1530–1539. [CrossRef] [PubMed]
65. Mizuta, M.; Endo, I.; Yamamoto, S.; Inokawa, H.; Kubo, M.; Udaka, T.; Sogabe, O.; Maeda, H.; Shirakawa, K.; Okazaki, E.; et al. Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: A prospective, randomized clinical trial. Biosci. Microbiota Food Health 2016, 35, 77–87. [CrossRef] [PubMed]
66. Yokoyama, Y.; Asahara, T.; Nomoto, K.; Nagino, M. Effects of Synbiotics to Prevent Postoperative Infectious Complications in Highly Invasive Abdominal Surgery. Ann. Nutr. Metab. 2017, 71, 23–30. [CrossRef]
67. Sugawara, G.; Nagino, M.; Nishio, H.; Ebata, T.; Takagi, K.; Asahara, T.; Nomoto, K.; Nimura, Y. Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer Surgery: A Randomized Controlled Trial. Ann. Surg. 2006, 244, 706–714. [CrossRef] [PubMed]
68. Zhang, Y.; Chen, J.; Wu, J.; Chalson, H.; Merigan, L.; Mitchell, A. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg. Nutr. 2013, 2, 6.
69. Rayes, N.; Hansen, S.; Seehofer, D.; Müller, A.R.; Serke, S.; Bengmark, S.; Neuhaus, P. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: A controlled trial in patients with major abdominal surgery. Nutrition 2002, 18, 609–615. [CrossRef]
70. Rayes, N.; Seehofer, D.; Hansen, S.; Boucsein, K.; Müller, A.R.; Serke, S.; Bengmark, S.; Neuhaus, P. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002, 74, 123–128. [CrossRef]
71. Rayes, N.; Seehofer, D.; Theruvath, T.; Schiller, R.A.; Langrehr, J.M.; Jonas, S.; Bengmark, S.; Neuhaus, P. Supply of Pre-and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation-A Randomized, Double-Blind Trial. Am. J. Transplant. 2005, 5, 125–130. [CrossRef]
72. Rayes, N.; Seehofer, D.; Theruvath, T.; Mogl, M.; Langrehr, J.M.; Nüssler, N.C.; Bengmark, S.; Neuhaus, P. Effect of Enteral Nutrition and Synbiotics on Bacterial Infection Rates After Pylorus-preserving Pancreatoduodenectomy: A Randomized, Double-blind Trial. Ann. Surg. 2007, 246, 36–41. [CrossRef]
73. Rayes, N.; Pilarski, T.; Stockmann, M.; Bengmark, S.; Neuhaus, P.; Seehofer, D. Effect of pre-and probiotics on liver regeneration after resection: A randomised, double-blind pilot study. Benef. Microbes 2012, 3, 237–244. [CrossRef] [PubMed]
74. Horvath, A.; Leber, B.; Schmerboeck, B.; Tawdrous, M.; Zettel, G.; Hartl, A.; Madl, T.; Stryeck, S.; Fuchs, D.; Lemesch, S.; et al. Randomised clinical trial: The effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment. Pharmacol. Ther. 2016, 44, 926–935. [CrossRef] [PubMed]
75. Komatsu, S.; Yokoyama, Y.; Nagino, M. Gut microbiota and bacterial translocation in digestive surgery: The impact of probiotics. Langenbeck’s Arch. Surg. 2017, 402, 401–416. [CrossRef] [PubMed]
76. Lynch, S.V.; Pedersen, O. The Human Intestinal Microbiome in Health and Disease. N. Engl. J. Med. 2016, 375, 2369–2379. [CrossRef] [PubMed]
77. Rizzatti, G.; Lopetuso, L.R.; Gibiino, G.; Binda, C.; Gasbarrini, A. Proteobacteria: A Common Factor in Human Diseases. Available online: https://www.hindawi.com/journals/bmri/2017/9351507/(accessed on 8 September 2018).
78. Lupp, C.; Robertson, M.L.; Wickham, M.E.; Sekirov, I.; Champion, O.L.; Gaynor, E.C.; Finlay, B.B. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2, 119–129. [CrossRef] [PubMed]
79. Hiippala, K.; Jouhten, H.; Ronkainen, A.; Hartikainen, A.; Kainulainen, V.; Jalanka, J.; Satokari, R. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018, 10, 988. [CrossRef]
80. Fukuda, S.; Toh, H.; Hase, K.; Oshima, K.; Nakanishi, Y.; Yoshimura, K.; Tobe, T.; Clarke, J.M.; Topping, D.L.; Suzuki, T.; et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469, 543–547. [CrossRef]
81. Canani, R.B.; Costanzo, M.D.; Leone, L.; Pedata, M.; Meli, R.; Calignano, A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 2011, 17, 1519–1528. [CrossRef]
82. Hayakawa, M.; Asahara, T.; Henzan, N.; Murakami, H.; Yamamoto, H.; Mukai, N.; Minami, Y.; Sugano, M.; Kubota, N.; Uegaki, S.; et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig. Dis. Sci. 2011, 56, 2361–2365. [CrossRef]
83. Gantois, I.; Ducatelle, R.; Pasmans, F.; Haesebrouck, F.; Hautefort, I.; Thompson, A.; Hinton, J.C.; Van Immerseel, F. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl. Environ. Microbiol. 2006, 72, 946–949. [CrossRef]
84. Seal, J.B.; Morowitz, M.; Zaborina, O.; An, G.; Alverdy, J.C. The molecular Koch’s postulates and surgical infection: A view forward. Surgery 2010, 147, 757–765. [CrossRef] [PubMed]
85. Olivas, A.D.; Shogan, B.D.; Valuckaite, V.; Zaborin, A.; Belogortseva, N.; Musch, M.; Meyer, F.; Trimble, W.L.; An, G.; Gilbert, J.; et al. Intestinal tissues induce an SNP mutation in Pseudomonas aeruginosa that enhances its virulence: Possible role in anastomotic leak. PLoS ONE 2012, 7, e44326. [CrossRef] [PubMed]
86. Furusawa, Y.; Obata, Y.; Fukuda, S.; Endo, T.A.; Nakato, G.; Takahashi, D.; Nakanishi, Y.; Uetake, C.; Kato, K.; Kato, T.; et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504, 446–450. [CrossRef] [PubMed]
87. Inan, M.S.; Rasoulpour, R.J.; Yin, L.; Hubbard, A.K.; Rosenberg, D.W.; Giardina, C. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 2000, 118, 724–734. [CrossRef]
88. Kelly, C.J.; Zheng, L.; Campbell, E.L.; Saeedi, B.; Scholz, C.C.; Bayless, A.J.; Wilson, K.E.; Glover, L.E.; Kominsky, D.J.; Magnuson, A.; et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe 2015, 17, 662–671. [CrossRef] [PubMed]
89. Al-Lahham, S.H.; Peppelenbosch, M.P.; Roelofsen, H.; Vonk, R.J.; Venema, K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 2010, 1801, 1175–1183. [CrossRef] [PubMed]
90. Lawhon, S.D.; Maurer, R.; Suyemoto, M.; Altier, C. Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol. Microbiol. 2002, 46, 1451–1464. [CrossRef]
91. Dannhardt, G.; Lehr, M. Nonsteriodal Antiinflammatory Agents, XVII: Inhibition of Bovine Cyclooxygenase and 5-Lipoxygenase by N-Alkyldiphenyl-pyrrolyl Acetic and Propionic Acid Derivatives. Arch. Pharm. 1993, 326, 157–162. [CrossRef]
92. Bos, C.L.; Richel, D.J.; Ritsema, T.; Peppelenbosch, M.P.; Versteeg, H.H. Prostanoids and prostanoid receptors in signal transduction. Int. J. Biochem. Cell Biol. 2004, 36, 1187–1205. [CrossRef]
93. Curi, R.; Bond, J.A.; Calder, P.C.; Newsholme, E.A. Propionate regulates lymphocyte proliferation and metabolism. Gen. Pharmacol. Vasc. Syst. 1993, 24, 591–597. [CrossRef]
94. Wajner, M.; Santos, K.D.; Schlottfeldt, J.L.; Rocha, M.P.; Wannmacher, C.M. Inhibition of mitogen-activated proliferation of human peripheral lymphocytes in vitro by propionic acid. Clin. Sci. 1999, 96, 99–103. [CrossRef] [PubMed]
95. Cavaglieri, C.R.; Nishiyama, A.; Fernandes, L.C.; Curi, R.; Miles, E.A.; Calder, P.C. Differential effects of short-chain fatty acids on proliferation and production of pro-and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003, 73, 1683–1690. [CrossRef]
96. Luk, G.D.; Bayless, T.M.; Baylin, S.B. Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity. J. Clin. Investig. 1980, 66, 66–70. [CrossRef] [PubMed]
97. Buffoni, F. Histaminase and Related Amine Oxidases. Pharmacol. Rev. 1966, 18, 1163–1199. [PubMed]
98. Honzawa, Y.; Nakase, H.; Matsuura, M.; Chiba, T. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability. Inflamm. Bowel Dis. 2011, 17, E23–25. [CrossRef] [PubMed]
99. Kuhn, K.A.; Manieri, N.A.; Liu, T.-C.; Stappenbeck, T.S. IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury. PLoS ONE 2014, 9, e114195. [CrossRef] [PubMed]
100. Kuhn, K.A.; Schulz, H.M.; Regner, E.H.; Severs, E.L.; Hendrickson, J.D.; Mehta, G.; Whitney, A.K.; Ir, D.; Ohri, N.; Robertson, C.E.; et al. Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity. Mucosal Immunol. 2018, 11, 357–368. [CrossRef]
101. Henriksen, M.; Jahnsen, J.; Lygren, I.; Stray, N.; Sauar, J.; Vatn, M.H.; Moum, B.; IBSEN Study Group. C-reactive protein: A predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008, 57, 1518–1523. [CrossRef]
102. Mazidi, M.; Rezaie, P.; Ferns, G.A.; Vatanparast, H. Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients 2017, 9, 20. [CrossRef]
103. Mizuno, T.; Yokoyama, Y.; Nishio, H.; Ebata, T.; Sugawara, G.; Asahara, T.; Nomoto, K.; Nagino, M. Intraoperative bacterial translocation detected by bacterium-specific ribosomal rna-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies. Ann. Surg. 2010, 252, 1013–1019. [PubMed]
104. Nishigaki, E.; Abe, T.; Yokoyama, Y.; Fukaya, M.; Asahara, T.; Nomoto, K.; Nagino, M. The detection of intraoperative bacterial translocation in the mesenteric lymph nodes is useful in predicting patients at high risk for postoperative infectious complications after esophagectomy. Ann. Surg. 2014, 259, 477–484. [CrossRef] [PubMed]
105. Lederer, A.-K.; Pisarski, P.; Kousoulas, L.; Fichtner-Feigl, S.; Hess, C.; Huber, R. Postoperative changes of the microbiome: Are surgical complications related to the gut flora? A systematic review. BMC Surg. 2017, 17, 125. [CrossRef] [PubMed]
106. Knoop, K.A.; McDonald, K.G.; Kulkarni, D.H.; Newberry, R.D. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2016, 65, 1100–1109. [CrossRef] [PubMed]
107. Britton, R.A.; Young, V.B. Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficle. Gastroenterology 2014, 146, 1547–1553. [CrossRef] [PubMed]
108. NAP6 Report—The National Institute of Academic Anaesthesia. Available online: http://www.nationalau ditprojects.org.uk/NAP6Report (accessed on 26 May 2018).
109. Tanner, J.; Khan, D.; Aplin, C.; Ball, J.; Thomas, M.; Bankart, J. Post-discharge surveillance to identify colorectal surgical site infection rates and related costs. J. Hosp. Infect. 2009, 72, 243–250. [CrossRef]
110. Straatman, J.; Cuesta, M.A.; De Lange-de Klerk, E.S.; Van Der Peet, D.L. Hospital Cost-Analysis of Complications after Major Abdominal Surgery. DSU 2015, 32, 150–156. [CrossRef]
111. Healy, M.A.; Mullard, A.J.; Campbell, D.A.; Dimick, J.B. Hospital and Payer Costs Associated with Surgical Complications. JAMA Surg. 2016, 151, 823–830. [CrossRef]
112. Keenan, J.E.; Speicher, P.J.; Thacker, J.K.M.; Walter, M.; Kuchibhatla, M.; Mantyh, C.R. The preventive surgical site infection bundle in colorectal surgery: An effective approach to surgical site infection reduction and health care cost savings. JAMA Surg. 2014, 149, 1045–1052. [CrossRef]